Health
Pelacarsen Cut Lp(a) by 78 Per Cent but Not Heart Attacks, Strokes or Deaths in the Lp(a)HORIZON Trial
Presented in Chicago and published in NEJM, an 8,300-patient trial found that a drug which slashes a genetic heart-risk factor did nothing for outcomes, leaving the field in doubt.
Nov 8, 2026
